Relapsed Acute Lymphoblastic Leukaemia: What Families in India Should Know

Acute lymphoblastic leukaemia (ALL) is a blood cancer that starts in the bone marrow. It is the most common cancer in children, but adults get it too. Most patients go into remission after the first round of treatment. For some, the disease comes back. Doctors call this relapsed ALL. When it does not respond to treatment at all, they call it refractory ALL.

Why does ALL come back?

Even after a good response, a small number of leukaemia cells can stay hidden in the bone marrow. Standard tests may not find them. Doctors use a test called MRD (measurable residual disease) to look for these cells. A positive MRD result often means a higher chance of relapse, so the treatment plan may change early.

Treatment options after a relapse

The right choice depends on the patient's age, the type of ALL, how long the first remission lasted and the patient's general health. Common options are:

• Chemotherapy again, often with a different combination of drugs.
• Targeted medicines for ALL with the Philadelphia chromosome.
• Immunotherapy, which helps the body's own immune cells attack the leukaemia.
• Stem cell (bone marrow) transplant, usually once the disease is back in remission.
• CAR-T cell therapy at a few specialised centres.

Newer immunotherapy medicines

Blinatumomab (brand name Blincyto) is one immunotherapy used for B-cell ALL. It links the patient's T-cells to the leukaemia cells so the T-cells can destroy them. It is given as a continuous drip over several weeks in hospital or with a portable pump. Like every cancer medicine, it has side effects that need close monitoring, and only the treating haematologist can decide if it suits a patient.

When a medicine is not stocked in India

Some newer cancer medicines are approved abroad years before they reach Indian chemists. In such cases, India's drug rules allow a medicine to be imported for one named patient, against a doctor's prescription and with government permission. Families who want to know more about Blincyto in India can read about its approved uses, dosage form and storage before speaking to their doctor.

Support during treatment

Treatment for relapsed ALL can take many months. Patients often need frequent blood tests, hospital stays and transfusions. Infections are a real risk because both the disease and the treatment lower the body's defences. Families can help by keeping the home clean, making sure everyone washes hands, and reporting fever to the hospital straight away instead of waiting.

Good food, enough rest and emotional support also matter. Many cancer hospitals in India have counsellors, dietitians and patient support groups. Some charitable trusts and government schemes help with part of the treatment cost, so it is worth asking the hospital's social worker about them early. Children with ALL may also need help to keep up with school during long breaks.

A few practical tips for families

• Ask the doctor for the exact type of ALL and the MRD result.
• Keep all reports, prescriptions and discharge summaries in one file.
• Ask about the cost and timeline of each option before treatment begins.
• Do not buy cancer medicines from unknown sellers online.

A relapse is hard news, but there are more treatment options for ALL today than ever before. Talking openly with the care team is the best first step.